RUOZI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.260
EU - Europa 17.175
AS - Asia 14.783
SA - Sud America 2.024
AF - Africa 357
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 24
Totale 66.673
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.774
GB - Regno Unito 4.993
IT - Italia 4.396
CN - Cina 4.088
SG - Singapore 4.086
SE - Svezia 3.137
HK - Hong Kong 1.849
BR - Brasile 1.547
VN - Vietnam 1.528
DE - Germania 950
UA - Ucraina 653
TR - Turchia 650
RU - Federazione Russa 639
BD - Bangladesh 638
FI - Finlandia 606
FR - Francia 554
KR - Corea 491
IN - India 368
BG - Bulgaria 245
CA - Canada 225
NL - Olanda 188
ID - Indonesia 173
AR - Argentina 154
IQ - Iraq 136
MX - Messico 131
JP - Giappone 125
IE - Irlanda 118
ZA - Sudafrica 112
ES - Italia 105
RO - Romania 91
PK - Pakistan 89
BE - Belgio 85
PL - Polonia 83
AE - Emirati Arabi Uniti 75
EC - Ecuador 74
CO - Colombia 72
LT - Lituania 62
CH - Svizzera 49
VE - Venezuela 48
EG - Egitto 47
MY - Malesia 46
IR - Iran 45
AU - Australia 41
MA - Marocco 41
CL - Cile 40
PH - Filippine 40
UZ - Uzbekistan 37
PY - Paraguay 36
CZ - Repubblica Ceca 32
JO - Giordania 31
AT - Austria 30
IL - Israele 30
TN - Tunisia 30
SA - Arabia Saudita 29
DZ - Algeria 28
TH - Thailandia 28
JM - Giamaica 27
NP - Nepal 25
PT - Portogallo 24
GR - Grecia 23
KE - Kenya 22
TW - Taiwan 22
CR - Costa Rica 19
UY - Uruguay 19
AZ - Azerbaigian 17
ET - Etiopia 17
KZ - Kazakistan 17
EU - Europa 16
PE - Perù 16
BO - Bolivia 15
SN - Senegal 15
DK - Danimarca 14
KG - Kirghizistan 14
DO - Repubblica Dominicana 13
LB - Libano 13
RS - Serbia 13
TT - Trinidad e Tobago 13
AL - Albania 12
BY - Bielorussia 12
HU - Ungheria 12
HN - Honduras 10
PR - Porto Rico 10
NZ - Nuova Zelanda 9
OM - Oman 9
PA - Panama 9
KH - Cambogia 8
LY - Libia 8
PS - Palestinian Territory 8
QA - Qatar 8
CY - Cipro 7
HR - Croazia 7
LK - Sri Lanka 7
NI - Nicaragua 7
NO - Norvegia 7
AM - Armenia 6
EE - Estonia 6
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
MN - Mongolia 6
NG - Nigeria 6
Totale 66.558
Salva come PNG Salva come JPEG
Città #
Southend 3.817
Ashburn 2.926
Santa Clara 2.844
Singapore 2.501
Fairfield 2.350
Stockholm 1.818
Hong Kong 1.817
Chandler 1.757
Woodbridge 1.635
Hefei 1.335
Chicago 1.297
Jacksonville 1.265
Houston 1.096
San Jose 1.074
Seattle 998
Wilmington 992
Dearborn 954
Ann Arbor 918
Beijing 818
Cambridge 798
Los Angeles 779
Nyköping 775
London 633
Modena 542
Council Bluffs 512
Ho Chi Minh City 499
Seoul 431
Salt Lake City 386
The Dalles 384
New York 371
Izmir 359
Helsinki 355
Hanoi 340
Milan 294
Dallas 260
Princeton 249
Sofia 234
Eugene 220
San Diego 214
Lauterbourg 203
Buffalo 195
Rome 193
Tampa 180
Moscow 168
Bologna 166
Elk Grove Village 163
São Paulo 143
Shanghai 142
Munich 126
Des Moines 119
Orem 119
Jakarta 116
Redwood City 112
Frankfurt am Main 107
Lancaster 106
Tokyo 97
Bremen 94
Dublin 94
Fremont 90
Falls Church 88
Phoenix 83
Naples 82
Columbus 76
Miami 76
Brussels 73
Reggio Emilia 73
Chennai 69
Sterling 69
Boardman 64
Florence 62
Da Nang 59
Guangzhou 59
Haiphong 59
Toronto 56
Dulles 54
Johannesburg 54
Warsaw 54
Turin 53
Montreal 52
Parma 52
Amsterdam 51
Baghdad 49
Brooklyn 49
Catania 47
Atlanta 46
Detroit 46
Nanjing 44
Bari 42
Como 42
Denver 40
Mexico City 39
Norwalk 38
Kent 37
Rio de Janeiro 37
Washington 36
Boston 35
Kansas City 35
Miano 35
Tulare 33
Manchester 32
Totale 45.760
Salva come PNG Salva come JPEG
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.033
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 593
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 506
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 493
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 476
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 466
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 460
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 456
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 444
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 436
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 431
Cationic liposomes for gene transfection 421
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 421
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 420
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 418
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 414
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 408
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 406
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 399
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 399
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 398
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 395
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 392
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 387
Amphiphilic ion pairs of tobramycin with lipoamino acids 387
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 379
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 376
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 373
Nanoparticle transport across the blood brain barrier 369
Polymeric nanoparticles for the drug delivery to the central nervous system 369
Vegetable cells in Papanicolaou-stained cervical smears 368
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 368
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 367
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 365
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 362
Nanomedicine: the future for advancing medicine and neuroscience 361
Brain targeting with polymeric nanoparticles: which administration route should we take? 361
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 360
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 359
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 358
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 355
Protein corona and nanoparticles: How can we investigate on? 352
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 348
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 348
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 346
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 345
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 342
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation 338
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 335
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 334
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 332
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 331
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 331
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 331
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 330
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 330
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 329
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 329
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 329
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 327
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 326
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 325
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 323
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 322
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 320
Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. 319
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 318
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 318
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 315
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 314
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 314
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 313
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 313
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 312
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 311
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 309
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 308
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 308
Functionalization of liposomes: microscopical methods for preformulative screening 306
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 306
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 305
Colloidal systems for CNS drug delivery 302
PLA/PLGA nanoparticles for sustained release of docetaxel 302
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 299
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 298
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 298
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 296
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 296
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 295
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 291
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 284
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 282
Preformulative and formulative studies on inclusion complexes between cyclodextrins and ursodeoxycholic acid 282
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 277
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 275
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 274
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 272
Brain targeting by engineered nanoparticles 272
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 271
Totale 36.807
Salva come PNG Salva come JPEG
Categoria #
all - tutte 248.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 248.075
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021278 0 0 0 0 0 0 0 0 0 0 0 278
2021/20224.234 189 486 381 289 161 212 238 229 498 332 698 521
2022/20234.919 592 536 401 482 569 711 116 437 578 91 188 218
2023/20243.460 177 202 220 286 732 356 396 426 127 89 148 301
2024/202511.116 526 176 238 820 2.136 1.467 897 755 1.082 503 1.148 1.368
2025/202623.689 1.329 851 1.566 2.785 4.348 1.379 2.238 1.032 3.875 1.985 1.172 1.129
Totale 67.084